Search research articles
Contact Us
Filters
Showing results (131-140 of 387) with videos related to
Page
of 39
Sort By:
Frontiers in Immunology
|
August 28, 2020
Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers
Helen He, Caroline M Olesen, Ana B Pavel, et al.
Experimental Dermatology
|
October 18, 2018
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition
Emma Guttman-Yassky, Jon M Hanifin, Mark Boguniewicz, et al.
The British Journal of Dermatology
|
June 5, 2024
The role of OX40 ligand/OX40 axis signalling in atopic dermatitis
Emma Guttman-Yassky, Michael Croft, Bob Geng, et al.
Archives of Dermatological Research
|
July 23, 2024
Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
Eden David, Neda Shokrian, Ester Del Duca, et al.
Experimental Dermatology
|
April 22, 2021
A plea for standardization of confocal microscopy and optical coherence tomography parameters to evaluate physiological and para-physiological skin conditions in cosmetic science
Silvana Ciardo, Claudia Pezzini, Stefania Guida, et al.
Archives of Dermatological Research
|
April 29, 2025
Systemic Janus kinase inhibitors in the management of granuloma annulare
Scott Stratman, Shivkar Amara, Kathryn Jayne Tan, et al.
Nature Reviews. Disease Primers
|
November 6, 2025
Alopecia areata
Benjamin Ungar, Yael Renert-Yuval, Ncoza C Dlova, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 21, 2019
Atopic Dermatitis Endotypes Based on Allergen Sensitization, Reactivity to Staphylococcus aureus Antigens, and Underlying Systemic Inflammation
Alexandra Leonard, Jingya Wang, Li Yu, et al.
Advances in Therapy
|
January 7, 2024
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study
Emma Guttman-Yassky, Eric L Simpson, Kristian Reich, et al.
Lancet (London, England)
|
December 12, 2022
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
Emma Guttman-Yassky, Eric L Simpson, Kristian Reich, et al.
Page
of 39
Search research articles
Search
Showing results (131-140 of 387) with videos related to
Sort By:
Page
of 39
Frontiers in Immunology
|
August 28, 2020
Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers
Helen He, Caroline M Olesen, Ana B Pavel, et al.
Experimental Dermatology
|
October 18, 2018
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition
Emma Guttman-Yassky, Jon M Hanifin, Mark Boguniewicz, et al.
The British Journal of Dermatology
|
June 5, 2024
The role of OX40 ligand/OX40 axis signalling in atopic dermatitis
Emma Guttman-Yassky, Michael Croft, Bob Geng, et al.
Archives of Dermatological Research
|
July 23, 2024
Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
Eden David, Neda Shokrian, Ester Del Duca, et al.
Experimental Dermatology
|
April 22, 2021
A plea for standardization of confocal microscopy and optical coherence tomography parameters to evaluate physiological and para-physiological skin conditions in cosmetic science
Silvana Ciardo, Claudia Pezzini, Stefania Guida, et al.
Archives of Dermatological Research
|
April 29, 2025
Systemic Janus kinase inhibitors in the management of granuloma annulare
Scott Stratman, Shivkar Amara, Kathryn Jayne Tan, et al.
Nature Reviews. Disease Primers
|
November 6, 2025
Alopecia areata
Benjamin Ungar, Yael Renert-Yuval, Ncoza C Dlova, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 21, 2019
Atopic Dermatitis Endotypes Based on Allergen Sensitization, Reactivity to Staphylococcus aureus Antigens, and Underlying Systemic Inflammation
Alexandra Leonard, Jingya Wang, Li Yu, et al.
Advances in Therapy
|
January 7, 2024
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study
Emma Guttman-Yassky, Eric L Simpson, Kristian Reich, et al.
Lancet (London, England)
|
December 12, 2022
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
Emma Guttman-Yassky, Eric L Simpson, Kristian Reich, et al.
Page
of 39